6 completed, 1 terminated, 1 unknown, 1 withdrawn. 4 Phase 4, 3 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 3, Unknown 1 |
| Phase 1 | 3 | Completed 3 |
| Not applicable | 1 | Terminated 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Omeprazole 20mg: new trials by email Literature Review of Omeprazole 20mg trials Research Report on Omeprazole 20mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets Omeprazole 20mg, Vitamin C - Hypochlorhydria | Phase 1 | Completed | Indiana University | 11 | 2021-10-01 | 2025-09-22 |
| Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. Aspirin 75mg, Clopidogrel 75mg, Rivaroxaban 2.5 MG - COVID-19 | Not applicable | Terminated | Imperial College London | 320 | 2020-04-03 | 2023-01-18 |
| A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis Omeprazole 20mg, Esomeprazole 20mg, Rabeprazole Sodium 20mg - Helicobacter Pylori Infection | Phase 4 | Unknown | Changi General Hospital | 252 | 2019-04-16 | 2020-10-08 |
| Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM Foralumab, placebo, Omeprazole 20mg - NASH - Nonalcoholic Steatohepatitis, NAFLD | Phase 2 | Withdrawn | Tiziana Life Sciences LTD | 2017-12-01 | 2019-09-12 | |
| Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS Neobianacid®, Omeprazole 20mg, Neobianacid® placebo - GERD, EPS | Phase 4 | Completed | Aboca Spa Societa' Agricola | 275 | 2017-09-12 | 2022-11-21 |
| Study to Compare the Bioavailability of Omeprazole 20 mg Before and After Undergoing Surgery for Morbid Obesity Omeprazole 20mg - Bariatric Surgery Candidate | Phase 4 | Completed | Emilio Vargas Castrillón | 43 | 2014-10-31 | 2019-02-25 |
| Clinical Trials on Evaluate the Red Ginseng and Fermented-Red Ginseng Affect to Drug Metabolizing Enzyme and Transporter in Healthy Volunteers CYP cocktail, Fexofenadine 30mg, Red ginseng - Healthy | Phase 1 | Completed | Chonbuk National University Hospital | 30 | 2013-09-01 | 2014-02-06 |
| Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis Omeprazole 20mg - Systemic Sclerosis, Gastroesophageal Reflux | Phase 1 | Completed | Khon Kaen University | 250 | 2013-05-01 | 2018-06-21 |
| Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis Omeprazole 20mg, Placebo oral capsule - Laryngopharyngeal Reflux, Chronic Rhinosinusitis (Diagnosis) | Phase 4 | Completed | Children's Hospital Srebrnjak | 60 | 2010-01-01 | 2020-12-30 |
Gastroesophageal Reflux (2) · Achlorhydria (1) · COVID-19 (1) · Coronavirus Infections (1) · Diabetes Mellitus, Type 2 (1) · Disease (1) · Laryngopharyngeal Reflux (1) · Non-alcoholic Fatty Liver Disease (1) · Scleroderma, Systemic (1)
Aboca Spa Societa' Agricola (1) · Changi General Hospital (1) · Children's Hospital Srebrnjak (1) · Chonbuk National University Hospital (1) · Emilio Vargas Castrillón (1) · Imperial College London (1) · Indiana University (1) · Khon Kaen University (1) · Tiziana Life Sciences LTD (1)
Italy (1) · Singapore (1) · South Korea (1) · Spain (1) · United Kingdom (1) · United States (1)
Dal-Sik Kim, PhD, MD (1) · Daphne Shih Wen Ang, MD (1) · Min-Gul Kim, MD (1) · Prapa Kanagaratnam, FRCP, PhD (1)
PMID 27495955, PMID 27746690, PMID 29024410, PMID 37307528, PMID 42226497